Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enovis Corp (ENOV)
The Enovis share price today is 26.52, view NYSE ENOV stock exchange data. Track the latest Enovis share price with real-time updates on ENOV stock performance including market cap, day range, 52-week range and dividend yield. Access ENOV charts, earnings dates and analyst estimates to support your investment decisions.
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.23
27.89
52 wk Range
21.00
37.85
ENOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.2327.89
52 wk Range
21.0037.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
43.64
Upside
+64.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Enovis Corp For: 7 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 43.64
(+64.54% Upside)
Enovis Corp Earnings Call Summary for Q1/2026
- Enovis Q1 2026 EPS of $0.89 beat estimates by 9.88%; revenue hit $589M, exceeding forecasts by 2.79%, driving shares up 4.23% to $25.90.
- Reconstruction segment led with 6% organic growth (days-adjusted); company posted 5% YoY revenue growth and 62% adjusted gross margin, up 40bps.
- CEO McDonald emphasized innovation strategy with ARVIS system adoption; company reaffirmed 2026 guidance with revenues split evenly between halves.
- Free cash flow conversion projected to exceed 25% for 2026; extremities and hip markets expected to drive continued growth throughout the year.
- Key risks include supply chain disruptions, tariff pressures on Prevention & Recovery segment, and macroeconomic uncertainties affecting global demand.
Last Updated: 07-05-2026, 09:48 pm
Read Full TranscriptEarnings
Latest Release
07-05-2026
EPS / Forecast
0.89 / 0.81
Revenue / Forecast
589M / 573.02M
Compare ENOV to Peers and Sector
Metrics to compare | ENOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −7.5x | −0.6x | |
PEG Ratio | 0.03 | −1.42 | 0.00 | |
Price/Book | 1.0x | 3.0x | 2.6x | |
Price / LTM Sales | 0.7x | 2.5x | 3.2x | |
Upside (Analyst Target) | 81.1% | 51.1% | 48.1% | |
Fair Value Upside | Unlock | 19.0% | 5.8% | Unlock |
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Enovis (ENOV) Share Price Today?
The Enovis share price today is 26.52.
What is the current Enovis (ENOV) share price and day range?
As of 08-05-2026, the Enovis share price is 26.52, with a previous close of 27.25. The share price has ranged from 26.23 to 27.89 today, while the 52-week range spans from 21.00 to 37.85.
What Is the Enovis Market Cap?
As of today, Enovis market cap is 1.57B.
What Is the Enovis (ENOV) Share Price Target?
The average 12-month share price target for Enovis is 43.64, with a high estimate of 55 and a low estimate of 33. 11 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +64.54% Upside potential.
What Is Enovis's Earnings Per Share (TTM)?
The Enovis EPS (TTM) is -19.88.
When Is the Next Enovis Earnings Date?
Enovis will release its next earnings report on 30-07-2026.
From a Technical Analysis Perspective, Is ENOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Enovis Trade On?
Enovis is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Enovis?
The stock symbol for Enovis is "ENOV."
How Many Times Has Enovis Stock Split?
Enovis has split 1 times.
How Many Employees Does Enovis Have?
Enovis has 7802 employees.
What Is the ENOV Premarket Price?
ENOV's last pre-market stock price is 27.35. The pre-market share volume is 400.00, and the stock has changed by 0.10, or 0.37%.
What Is the ENOV After Hours Price?
ENOV's last after hours stock price is 27.04, the stock has changed by 0.52, or 1.96%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.